Articles about Nohla Therapeutics

Founded last year, Mozart Therapeutics lands $55M to develop therapies for celiac and other diseases

A year and a few months since its founding, Mozart Therapeutics has secured $55 million to develop therapies for celiac… Read More

Tech Moves: Nohla Therapeutics hires chief medical officer; Apptio adds to board; and more

Seattle biotech startup Nohla Therapeutics has an ambitious goal: Make umbilical stem cell transplants, currently a rare procedure, the new… Read More

Nohla Therapeutics raises another $11M to support leukemia treatment trials

Seattle startup Nohla Therapeutics has reeled in another $11 million to further develop its leukemia treatment. The spinout of Seattle’s Fred Hutchinson Cancer… Read More

Nohla Therapeutics raises $45M, gets new HQ as it moves novel leukemia treatment closer to market

Seattle startup Nohla Therapeutics has raised another huge funding round as it moves its novel leukemia treatment closer to being… Read More

Tech Moves: Amazon hires top doc; Geir Hansen leaves SVB; Acumatica board adds ex-Microsoft Business Solutions chief

Amazon is continuing to bolster its health care game. The company recently hired Dr. Martin Levine, a longtime Seattle doctor… Read More

Tech Moves: Apple poaches Amazon Fire exec; Tune promotes Koch to CTO; Nohla names CEO; etc.

—Apple and Amazon are on a collision course in many industries, but the battle for tech talent looks to be… Read More

Fred Hutch spinout Nohla Therapeutics raises $43.5M to develop therapy for Leukemia

Seattle-based Nohla Therapeutics, a biotech startup spun out of the Fred Hutchinson Cancer Research Center, just announced a whopping $43.5 million… Read More

Fred Hutchinson Cancer Research Center spins out disease-fighting biotech startup Nohla Therapeutics

Nohla Therapeutics just became the latest biotech startup to come out of the Fred Hutchinson Cancer Research Center. Like spinouts before it, Nohla is already… Read More